Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

HeartSciences (HSCS) Accumulated Depreciation & Amortization (2022 - 2026)

HeartSciences filings provide 5 years of Accumulated Depreciation & Amortization readings, the most recent being $558391.0 for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 5.39% to $558391.0 in Q1 2026 year-over-year; TTM through Jan 2026 was $558391.0, a 5.39% increase, with the full-year FY2025 number at $537358.0, up 7.52% from a year prior.
  • Accumulated Depreciation & Amortization hit $558391.0 in Q1 2026 for HeartSciences, up from $551475.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $558391.0 in Q1 2026 to a low of $444952.0 in Q2 2022.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $495158.5 (2024), compared with a mean of $500297.8.
  • The widest YoY moves for Accumulated Depreciation & Amortization: up 8.01% in 2025, down 5.28% in 2025.
  • HeartSciences' Accumulated Depreciation & Amortization stood at $458177.0 in 2022, then increased by 6.26% to $486841.0 in 2023, then increased by 7.6% to $523838.0 in 2024, then rose by 5.28% to $551475.0 in 2025, then rose by 1.25% to $558391.0 in 2026.
  • The last three reported values for Accumulated Depreciation & Amortization were $558391.0 (Q1 2026), $551475.0 (Q4 2025), and $544469.0 (Q3 2025) per Business Quant data.